Viewing Study NCT01362660


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2025-12-26 @ 2:13 AM
Study NCT ID: NCT01362660
Status: COMPLETED
Last Update Posted: 2013-02-06
First Post: 2011-05-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Infants With Potential Exposure to Tanezumab Before Birth
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module